The award is among the highest distinctions given to medical and biological engineers
By Lindsay Brownell
(CAMBRIDGE, Mass.) — The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Wyss Core Faculty member Jennifer Lewis, Ph.D. to its College of Fellows. A formal induction ceremony was held during the AIMBE Annual Meeting at the National Academy of Sciences in Washington, DC on April 9, 2018, where Dr. Lewis was inducted along with 156 colleagues into the AIMBE College of Fellows Class of 2018.
The College of Fellows is comprised of the top two percent of medical and biological engineers, and honors those who have made outstanding contributions to “engineering and medicine research, practice, or education,” and to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering, or developing/implementing innovative approaches to bioengineering education.” Fellows work towards realizing AIMBE’s vision to provide medical and biological engineering innovation for the benefit of humanity.
Dr. Lewis was nominated, reviewed, and elected by peers and members of the College of Fellows for her pioneering contributions to the fields of materials science and 3D printing, and their application to device fabrication and biomanufacturing. She is also the Hansjörg Wyss Professor of Biologically Inspired Engineering at Harvard’s John A. Paulson School of Engineering and Applied Sciences (SEAS) and the inaugural Jianming Yu Professor of Arts and Sciences at Harvard University’s Faculty of Arts and Sciences (FAS).
“I am deeply honored to join the ranks of an organization whose mission mirrors the Wyss Institute’s commitment to advance biologically inspired engineering solutions that improve people’s lives,” Lewis said. “I look forward to further contributing to society as a member of the AIMBE.”
AIMBE was founded in 1991 with the mission to provide leadership and advocacy in medical and biological engineering for the benefit of society. It represents some 50,000 individuals, as well as academic institutions, private industry, and professional engineering societies. The organization is tasked with contributing to public policy-making to advance medical and biological engineering and benefit the general public, and works to ensure appropriate private and public investment in advance medical and biological engineering translational research and innovation.